Experienced in Wilms Tumor

Qianjin B. Lu

139 Ren Min Road, 
Changsha, CN 
Experienced in Wilms Tumor
139 Ren Min Road, 
Changsha, CN 
OverviewLocationsClinical Research

Overview

Qianjin Lu practices in Changsha, China. Lu is rated as an Experienced expert by MediFind in the treatment of Wilms Tumor. Their top areas of expertise are Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), Lymphadenectomy, and Hysterectomy.

Their clinical research consists of co-authoring 392 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Wilms Tumor.

Locations

139 Ren Min Road, Changsha, 410011, China
Other Locations
160 Pujian Rd, Shanghai, 200127, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Jaktinib in Adult Patients With Severe Alopecia Areata
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Jaktinib in Adult Patients With Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: March 14, 2025
Intervention Type: Drug
Study Drug: Jaktinib
Study Phase: Phase 3
A Multi-center,Randomized,Double-blind,Placebo,Parallel-controlled Phase II Clinical Study of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis Patients
A Multi-center,Randomized,Double-blind,Placebo,Parallel-controlled Phase II Clinical Study of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis Patients
Enrollment Status: Completed
Publish Date: March 24, 2023
Intervention Type: Drug
Study Drug: Jacketinib
Study Phase: Phase 2
An Open-label Study for Assessing the Efficacy and Safety of Nicotinamide Treatment for Lupus-associated Skin Lesions in Patients With Cutaneous Lupus Erythematosus or Systemic Lupus Erythematosus
An Open-label Study for Assessing the Efficacy and Safety of Nicotinamide Treatment for Lupus-associated Skin Lesions in Patients With Cutaneous Lupus Erythematosus or Systemic Lupus Erythematosus
Enrollment Status: Unknown
Publish Date: February 02, 2021
Intervention Type: Drug
Study Drug: Nicotinamide
Study Phase: Phase 2
View 2 Less Clinical Trials

392 Total Publications

Methods and practical applications of clinical prediction model development
Methods and practical applications of clinical prediction model development
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile